2024 House Bill 5519

Economic development: Michigan strategic fund; insulin production program; include in report of activities.

A bill to amend 1984 PA 270, entitled “Michigan strategic fund act,” by amending section 9 (MCL 125.2009), as amended by 2021 PA 136.

Official record

House Fiscal Agency Analysis

Taken together, House Bills 4890 and 5519 would amend the Michigan Strategic Fund Act to require the Michigan Strategic Fund (MSF) to create and operate a program to make and distribute insulin in partnership with a private sector entity. The bills would provide requirements for contractors selected to be partners under the program, prescribe provisions to be included in contractor agreements, allow MSF to make grants related to the program, create the Insulin Production Fund, provide for a temporary insulin distribution program while a production facility is being built, and require MSF to include information about the program in its annual report.

Introduced in the House

Feb. 22, 2024

Introduced by Rep. Jennifer Conlin (D-48) and 29 co-sponsors

Co-sponsored by Reps. Sharon MacDonell (D-56), Noah Arbit (D-20), Matt Koleszar (D-22), Carrie Rheingans (D-47), Christine Morse (D-40), Mike McFall (D-8), Denise Mentzer (D-61), Felicia Brabec (D-33), Betsy Coffia (D-103), Rachel Hood (D-81), Kara Hope (D-74), Kelly Breen (D-21), Penelope Tsernoglou (D-75), Jason Hoskins (D-18), Emily Dievendorf (D-77), Jason Morgan (D-23), Alabas Farhat (D-3), Veronica Paiz (D-11), Jenn Hill (D-109), Dylan Wegela (D-26), Jimmie Wilson (D-32), Reggie Miller (D-31), Jasper Martus (D-69), Timothy Beson (R-96), Jerry Neyer (R-92), Jim Haadsma (D-44), Ken Borton (R-105), Curtis VanderWall (R-102) and Robert Bezotte (R-50)

Referred to the Committee on Health Policy

May 22, 2024

Reported with substitute H-1